Rheum in Bloom

Ode to my immune system


 

Our bodies are amazing feats of nature

Pathways that we understand through science

Among the most complex though, I would wager

Immunity, autoimmunity, and balance.

First there is the issue of barriers,

Skin, and gut, and membranes

Primary defense against invaders

Seems ordinary, but really far from mundane.

What comes next is not pure serendipity

Not chance but an evolutionary gift

We kill germs with innate immunity

Imprecise but efficient and swift.

Phagocytes, a fitting name for greed

Neutrophils, macrophages, dendritic cells

Summoned to areas of injury, they proceed

To ingest and digest and clear dead cells.

Complement, a cascade of proteases

Opsonize invading pathogens

Activated by three different pathways

Membrane attack complex a terminal engine.

Simultaneously, adaptive immunity

In special regions, lymph nodes and Peyer’s patches

B cells develop some memory

Immunoglobulins churned out in batches.

Helper Ts aid antibody production

Cytotoxic Ts kill the bugs hiding within

Regulatory Ts promote self toleration

MHCs on cell surfaces weigh in.

Many elements require orchestration

Helped along by a bevy of proteins

Chemokines, interleukins, growth factors, interferons

Enzymatic cascades form routine.

This cellular/molecular adventure

Fantastically intricate choreography

Self or non-self, intruder, interloper

Defense against microbial tomfoolery.

Dr. Chan practices rheumatology is Pawtucket, R.I.

Recommended Reading

Methotrexate alone or with etanercept have equal efficacy for early inflammatory arthritis
MDedge Rheumatology
Hold the immunomodulators for surgery? Maybe yes, maybe no
MDedge Rheumatology
Apixaban approved for preventing DVT and pulmonary embolism after hip/knee surgery
MDedge Rheumatology
House passes bill to repeal the SGR
MDedge Rheumatology
Online reviews
MDedge Rheumatology
Liability and casualty insurance claims
MDedge Rheumatology
Autoimmune disease coalition seeks to increase physician knowledge
MDedge Rheumatology
Autoimmune patients report mixed results with new ACA coverage
MDedge Rheumatology
New interleukin-17 inhibitor improved RA in phase II trial
MDedge Rheumatology
Doctors may not get paid for care if patients don’t pay their ACA premiums
MDedge Rheumatology